Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Pregabalin Prescription for Neuropathic Pain and Fibromyalgia: A Descriptive Study Using Administrative Database in Japan.

Hirakata M, Yoshida S, Tanaka-Mizuno S, Kuwauchi A, Kawakami K.

Pain Res Manag. 2018 Jun 5;2018:2786151. doi: 10.1155/2018/2786151. eCollection 2018.

2.

Mechanisms of inhibitory action of TRK-130 (Naltalimide), a μ-opioid receptor partial agonist, on the micturition reflex.

Fujimura M, Izumimoto N, Kanie S, Kobayashi R, Yoshikawa S, Momen S, Hirakata M, Komagata T, Okanishi S, Iwata M, Hashimoto T, Doi T, Yoshimura N, Kawai K.

Int Urol Nephrol. 2017 Apr;49(4):587-595. doi: 10.1007/s11255-017-1509-y. Epub 2017 Jan 16.

PMID:
28093646
3.

Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys.

Nakao K, Hirakata M, Miyamoto Y, Kainoh M, Wakasa Y, Yanagita T.

J Pharmacol Sci. 2016 Jan;130(1):8-14. doi: 10.1016/j.jphs.2015.11.008. Epub 2015 Dec 2.

4.

A unique case of polymyositis with anti-signal recognition particle antibody complicated by subacute interstitial lung disease and subluxing arthropathy, resembling anti-synthetase syndrome.

Hanaoka H, Kaneko Y, Suzuki S, Takada T, Hirakata M, Takeuchi T, Kuwana M.

Mod Rheumatol. 2016 Nov;26(6):979-980. doi: 10.3109/14397595.2015.1129693. Epub 2016 Feb 16. No abstract available.

PMID:
26707188
5.

Anti-signal recognition particle antibody in patients without inflammatory myopathy: a survey of 6180 patients with connective tissue diseases.

Hanaoka H, Kaneko Y, Suzuki S, Takada T, Hirakata M, Takeuchi T, Kuwana M.

Scand J Rheumatol. 2016 Jan;45(1):36-40. doi: 10.3109/03009742.2015.1054876. Epub 2015 Aug 31.

PMID:
26312949
6.

Evaluation of the repeated-dose liver micronucleus assay using 2,4-dinitrotoluene: a report of a collaborative study by CSGMT/JEMS.MMS.

Maeda A, Tsuchiyama H, Asaoka Y, Hirakata M, Miyoshi T, Oshida K, Miyamoto Y.

Mutat Res Genet Toxicol Environ Mutagen. 2015 Mar;780-781:41-5.

PMID:
26065309
7.

Characteristics of TRK-130 (Naltalimide), a novel opioid ligand, as a new therapeutic agent for overactive bladder.

Fujimura M, Izumimoto N, Momen S, Yoshikawa S, Kobayashi R, Kanie S, Hirakata M, Komagata T, Okanishi S, Hashimoto T, Yoshimura N, Kawai K.

J Pharmacol Exp Ther. 2014 Sep;350(3):543-51. doi: 10.1124/jpet.114.214031. Epub 2014 Jun 13.

8.

Distinct arthropathies of the hands in patients with anti-aminoacyl tRNA synthetase antibodies: usefulness of autoantibody profiles in classifying patients.

Kaneko Y, Hanaoka H, Hirakata M, Takeuchi T, Kuwana M.

Rheumatology (Oxford). 2014 Jun;53(6):1120-4.

PMID:
24501248
9.

The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia.

Nakashima R, Imura Y, Hosono Y, Seto M, Murakami A, Watanabe K, Handa T, Mishima M, Hirakata M, Takeuchi T, Fujio K, Yamamoto K, Kohsaka H, Takasaki Y, Enomoto N, Suda T, Chida K, Hisata S, Nukiwa T, Mimori T.

PLoS One. 2014 Jan 14;9(1):e85062. doi: 10.1371/journal.pone.0085062. eCollection 2014.

10.

An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes.

Shimane K, Kochi Y, Suzuki A, Okada Y, Ishii T, Horita T, Saito K, Okamoto A, Nishimoto N, Myouzen K, Kubo M, Hirakata M, Sumida T, Takasaki Y, Yamada R, Nakamura Y, Kamatani N, Yamamoto K.

Rheumatology (Oxford). 2013 Jul;52(7):1172-82. doi: 10.1093/rheumatology/kes427. Epub 2013 Feb 12.

PMID:
23407388
11.

A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus eyrthematosus in Japanese.

Okada Y, Shimane K, Kochi Y, Tahira T, Suzuki A, Higasa K, Takahashi A, Horita T, Atsumi T, Ishii T, Okamoto A, Fujio K, Hirakata M, Amano H, Kondo Y, Ito S, Takada K, Mimori A, Saito K, Kamachi M, Kawaguchi Y, Ikari K, Mohammed OW, Matsuda K, Terao C, Ohmura K, Myouzen K, Hosono N, Tsunoda T, Nishimoto N, Mimori T, Matsuda F, Tanaka Y, Sumida T, Yamanaka H, Takasaki Y, Koike T, Horiuchi T, Hayashi K, Kubo M, Kamatani N, Yamada R, Nakamura Y, Yamamoto K.

PLoS Genet. 2012 Jan;8(1):e1002455. doi: 10.1371/journal.pgen.1002455. Epub 2012 Jan 26.

12.

Toxicological effect of emodin in mouse testicular gene expression profile.

Oshida K, Hirakata M, Maeda A, Miyoshi T, Miyamoto Y.

J Appl Toxicol. 2011 Nov;31(8):790-800. doi: 10.1002/jat.1637. Epub 2011 Feb 11.

PMID:
21319176
13.

[Pharmacological effects of nalfurafine hydrochloride, a kappa-opioid receptor agonist].

Nakao K, Hasebe K, Yoshikawa S, Ikeda K, Hirakata M, Miyamoto Y, Mochizuki H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Nov;30(5-6):185-91. Review. Japanese.

PMID:
21226314
14.

[Anti-Ku antibodies].

Hirakata M, Suwa A.

Nihon Rinsho. 2010 Jun;68 Suppl 6:572-4. Japanese. No abstract available.

PMID:
20942132
15.

[Anti-PL-7, anti-PL-12, and other anti-aminoacyl tRNA synthetase antibodies].

Hirakata M.

Nihon Rinsho. 2010 Jun;68 Suppl 6:555-9. Japanese. No abstract available.

PMID:
20942128
16.

[Anti-Jo-1(histidyl tRNA synthetase) antibodies].

Hirakata M.

Nihon Rinsho. 2010 Jun;68 Suppl 6:551-4. Japanese. No abstract available.

PMID:
20942127
17.

[Pharmacological and clinical profiles of nalfurafine hydrochloride (Remitch) capsules 2.5 microg) , a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients].

Nakao K, Ando A, Hirakata M, Ando N, Takeshita K, Miyamoto Y, Mochizuki H.

Nihon Yakurigaku Zasshi. 2010 May;135(5):205-14. Review. Japanese. No abstract available.

PMID:
20467170
18.

[The actual conditions and problems of terminal home nursing care at our hospital].

Hara T, Kawashiri H, Hirakata M, Yamasaki M, Sato M, Miura H, Murata T, Takagi H.

Gan To Kagaku Ryoho. 2009 Dec;36 Suppl 1:28-9. Japanese.

PMID:
20443392
19.

The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population.

Shimane K, Kochi Y, Horita T, Ikari K, Amano H, Hirakata M, Okamoto A, Yamada R, Myouzen K, Suzuki A, Kubo M, Atsumi T, Koike T, Takasaki Y, Momohara S, Yamanaka H, Nakamura Y, Yamamoto K.

Arthritis Rheum. 2010 Feb;62(2):574-9. doi: 10.1002/art.27190.

20.

Clinical associations with autoantibody reactivities to individual components of U1 small nuclear ribonucleoprotein.

Kaneko Y, Suwa A, Hirakata M, Ikeda Y, Kuwana M.

Lupus. 2010 Mar;19(3):307-12. doi: 10.1177/0961203309355163. Epub 2009 Dec 16.

PMID:
20015915
21.

Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies.

Takada T, Hirakata M, Suwa A, Kaneko Y, Kuwana M, Ishihara T, Ikeda Y.

Mod Rheumatol. 2009 Apr;19(2):165. doi: 10.3109/s10165-009-0165-1. No abstract available.

PMID:
28925310
22.

Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies.

Takada T, Hirakata M, Suwa A, Kaneko Y, Kuwana M, Ishihara T, Ikeda Y.

Mod Rheumatol. 2009;19(2):156-64. doi: 10.1007/s10165-008-0139-8. Epub 2008 Dec 17. Erratum in: Mod Rheumatol. 2009;19(2):165.

PMID:
19089533
23.

Successful treatment of refractory polymyositis with the immunosuppressant mizoribine: case report.

Suwa A, Hirakata M, Kaneko Y, Sato S, Suzuki Y, Kuwana M.

Clin Rheumatol. 2009 Feb;28(2):227-9. doi: 10.1007/s10067-008-1050-6. Epub 2008 Dec 9.

PMID:
19082529
24.

The human mirror neuron system in a population with deficient self-awareness: an fMRI study in alexithymia.

Moriguchi Y, Ohnishi T, Decety J, Hirakata M, Maeda M, Matsuda H, Komaki G.

Hum Brain Mapp. 2009 Jul;30(7):2063-76. doi: 10.1002/hbm.20653.

PMID:
18781590
25.

Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population.

Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M, Kameda H, Hirohata S, Kondo H, Kumagai S, Tanaka Y.

Rheumatology (Oxford). 2008 Sep;47(9):1373-8. doi: 10.1093/rheumatology/ken231. Epub 2008 Jun 24.

PMID:
18577548
26.

Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study.

Tokuda H, Sakai F, Yamada H, Johkoh T, Imamura A, Dohi M, Hirakata M, Yamada T, Kamatani N, Kikuchi Y, Sugii S, Takeuchi T, Tateda K, Goto H.

Intern Med. 2008;47(10):915-23. Epub 2008 May 15.

27.
28.

[Anti-signal recognition particle (SRP) antibody positive polymyositis refractory to corticosteroid treatment].

Shirai Y, Koizumi K, Ogawa R, Suzuki T, Koido N, Ohosone Y, Akizuki S, Takada T, Hirakata M, Ishihara T.

Nihon Naika Gakkai Zasshi. 2007 Nov 10;96(11):2522-4. Japanese. No abstract available.

PMID:
18069306
29.

Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.

Sato S, Takada T, Katsuki Y, Kimura N, Kaneko Y, Suwa A, Hirakata M, Kuwana M.

J Rheumatol. 2008 Jan;35(1):142-6. Epub 2007 Nov 15.

PMID:
18050368
30.

Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.

Nishimoto T, Ishikawa E, Anayama H, Hamajyo H, Nagai H, Hirakata M, Tozawa R.

Toxicol Appl Pharmacol. 2007 Aug 15;223(1):39-45. Epub 2007 May 24.

PMID:
17599378
31.

Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.

Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, Song YW, Mimori T, Targoff IN.

Arthritis Rheum. 2007 Apr;56(4):1295-303.

32.

Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.

Sato S, Kuwana M, Hirakata M.

Rheumatology (Oxford). 2007 May;46(5):842-5. Epub 2007 Jan 25.

PMID:
17255133
33.

Neural correlates for learning to read Roman numerals.

Masataka N, Ohnishi T, Imabayashi E, Hirakata M, Matsuda H.

Brain Lang. 2007 Mar;100(3):276-82. Epub 2007 Jan 10.

PMID:
17218001
34.

Unusual hemangioendothelioma of the liver with epithelioid morphology associated with marked eosinophilia: autopsy case.

Kimura T, Mukai M, Kaneko Y, Hirakata M, Okamoto S, Sakamoto M, Okada Y, Ikeda Y.

Pathol Int. 2006 Nov;56(11):694-701.

PMID:
17040294
35.

Sensorimotor polyneuropathy as an initial clinical manifestation of sarcoidosis.

Sato S, Nogawa S, Hirakata M, Iizuka H, Suwa A, Mimori T, Ikeda Y.

Mod Rheumatol. 2005;15(2):144-7.

PMID:
17029053
36.

[Anesthetic management of 7-9th total spondylectomy for severe scoliosis].

Shimizu K, Hirakata M, Ogawa K, Terauchi T, Arai T, Kuno Y, Inoue H, Okuda Y.

Masui. 2006 Jun;55(6):714-6. Japanese.

PMID:
16780082
37.

Navigation ability dependent neural activation in the human brain: an fMRI study.

Ohnishi T, Matsuda H, Hirakata M, Ugawa Y.

Neurosci Res. 2006 Aug;55(4):361-9. Epub 2006 Jun 2.

PMID:
16735070
38.
39.

Successful treatment of recurrent intracardiac thrombus in Behçet's disease with immunosuppressive therapy.

Kaneko Y, Tanaka K, Yoshizawa A, Yasuoka H, Suwa A, Satoh T, Iwanaga S, Ogawa S, Ikeda Y, Hirakata M.

Clin Exp Rheumatol. 2005 Nov-Dec;23(6):885-7.

PMID:
16396710
40.

Neural correlates for numerical processing in the manual mode.

Masataka N, Ohnishi T, Imabayashi E, Hirakata M, Matsuda H.

J Deaf Stud Deaf Educ. 2006 Spring;11(2):144-52. Epub 2005 Nov 30.

PMID:
16319374
41.

Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.

Nakamura M, Tanaka Y, Satoh T, Kawai M, Hirakata M, Kaburaki J, Kawakami Y, Ikeda Y, Kuwana M.

Rheumatology (Oxford). 2006 Feb;45(2):150-6. Epub 2005 Sep 27.

PMID:
16188945
42.

Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies.

Sato S, Hirakata M, Kuwana M, Nakamura K, Suwa A, Inada S, Mimori T, Ikeda Y.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):609-15.

PMID:
16173235
43.

[Immunologic tests: Anti-PL 7 antibodies, anti-PL-12 antibodies, and other anti-aminoacyl tRNA synthetase antibodies].

Hirakata M, Katsuki Y, Sato S.

Nihon Rinsho. 2005 Jul;63 Suppl 7:508-11. Review. Japanese. No abstract available.

PMID:
16111316
44.

[Immunologic tests: Anti-Jo-l antibody (anti-histidyl transfer RNA synthetase antibody)].

Katsuki Y, Hirakata M.

Nihon Rinsho. 2005 Jul;63 Suppl 7:505-7. Review. Japanese. No abstract available.

PMID:
16111315
45.

Autoantibodies to aminoacyl-tRNA synthetases.

Hirakata M.

Intern Med. 2005 Jun;44(6):527-8. No abstract available.

46.

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis.

Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, Nishikawa T, Oddis CV, Ikeda Y.

Arthritis Rheum. 2005 May;52(5):1571-6.

47.

Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis.

Okada T, Noji S, Goto Y, Iwata T, Fujita T, Okada T, Matsuzaki Y, Kuwana M, Hirakata M, Horii A, Matsuno S, Sunamura M, Kawakami Y.

Int J Cancer. 2005 Oct 10;116(6):925-33.

48.

Class-specific binding of two aminoacyl-tRNA synthetases to annexin, a Ca2+- and phospholipid-binding protein.

Shirakawa T, Nakamura A, Kohama K, Hirakata M, Ogihara S.

Cell Struct Funct. 2005 Feb;29(5-6):159-64.

49.

[immunological and serological tests for diagnosis of rheumatoid arthritis: antinuclear antibodies].

Hirakata M, Kaneko Y.

Nihon Rinsho. 2005 Jan;63 Suppl 1:333-40. Review. Japanese. No abstract available.

PMID:
15799373
50.

Association between autoantibodies to the Ku protein and DPB1*.

Hirakata M, Suwa A, Kuwana M, Sato S, Mimori T, Hardin JA.

Arthritis Rheum. 2005 Feb;52(2):668-9. No abstract available.

Supplemental Content

Loading ...
Support Center